List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 96 studies with search of: Allergic Conjunctivitis
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: R89674 0.025% ophthalmic solution
2 Completed Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: R89674 (generic name not yet established)
3 Completed Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: R89674 (generic name not yet established)
4 Completed Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: Ketotifen with a Contact Lens (generic name not yet established)
5 Completed Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: Ketotifen with a Contact Lens (no generic name)
6 Completed Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis
Condition: Seasonal Allergic Conjunctivitis
Intervention: Drug: Ketotifen
7 Completed Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: Ketotifen 4.0% Patch;   Drug: Placebo;   Drug: Olopatadine 0.2%;   Drug: Artificial tears
8 Active, not recruiting Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: bromfenac ophthalmic solution
9 Completed Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: olopatadine 0.2%
10 Completed A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Interventions: Drug: Olopatadine;   Drug: Fluticasone;   Drug: Saline;   Drug: Artificial tears
11 Completed Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: SAR 1118;   Other: Placebo
12 Active, not recruiting Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects
Condition: Allergic Conjunctivitis
Interventions: Drug: Olopatadine 0.2% + Olopatadine 0.2% vehicle;   Drug: Olopatadine 0.1% + Olopatadine 0.1% Vehicle
13 Active, not recruiting Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: bepotastine besilate ophthalmic solution;   Drug: placebo comparator
14 Completed
Has Results 		Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: Elestat;   Drug: Pataday
15 Active, not recruiting Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Intervention: Drug: bepotastine besilate
16 Active, not recruiting Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
Condition: Allergic Conjunctivitis
Intervention: Drug: Tacrolimus 0.03% ointment (Protopic)
17 Not yet recruiting Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.
Condition: Allergic Conjunctivitis
Interventions: Drug: Ketotifen/naphazoline;   Drug: Ketotifen/naphazoline and Vehicle;   Drug: Ketotifen/naphazoline and Naphazoline;   Drug: Ketotifen/naphazoline and Ketotifen;   Drug: Ketotifen and Ketotifen/naphazoline;   Drug: Ketotifen and Vehicle;   Drug: Ketotifen and Naphazoline;   Drug: Ketotifen;   Drug: Naphazoline and Ketotifen/naphazoline;   Drug: Naphazoline and Vehicle;   Drug: Naphazoline;   Drug: Naphazoline and Ketotifen;   Drug: Vehicle and Ketotifen/naphazoline;   Drug: Vehicle;   Drug: Vehicle and Naphazoline;   Drug: Vehicle and Ketotifen
18 Completed Evaluation of a Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis.
Condition: Allergic Conjunctivitis
Interventions: Drug: Ketotifen/naphazoline;   Drug: Ketotifen/naphazoline & Vehicle;   Drug: Ketotifen/naphazoline and Naphazoline;   Drug: Ketotifen/naphazoline and Ketotifen;   Drug: Ketotifen and Ketotifen/naphazoline;   Drug: Ketotifen and vehicle;   Drug: Ketotifen and Naphazoline;   Drug: Ketotifen;   Drug: Naphazoline and Ketotifen/naphazoline;   Drug: Naphazoline and Vehicle;   Drug: Naphazoline;   Drug: Naphazoline and Ketotifen;   Drug: Vehicle and Ketotifen/naphazoline;   Drug: Vehicle;   Drug: Vehicle and Naphazoline;   Drug: Vehicle and Ketotifen
19 Not yet recruiting AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation
Condition: Allergic Conjunctivitis Associated Inflammation
Interventions: Drug: AL-38583 Ophthalmic Solution;   Drug: AL-38583 Ophthalmic Solution Vehicle;   Drug: Dexamethasone Ophthalmic Suspension
20 Completed Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge Model
Condition: Allergic Conjunctivitis
Interventions: Drug: Prednisolone Acetate 1%;   Drug: Prednisolone Acetate 0.12%;   Drug: Loteprednol Etabonate 0.2%;   Drug: Artificial tears

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services